Updates
** Pfizer's PFE.N shares rise 4.4% to $24.06
** Stock set for its biggest single-day pct. jump in nearly 4 months, if gains hold
** PFE posts Q1 adj. EPS of $0.92, beating analysts' estimates of $0.67, according to data compiled by LSEG
** PFE's Q1 revenue misses estimates due to declining sales of its Paxlovid COVID-19 treatment, but co still sticks by FY revenue forecast of $61 billion-$64 billion
** Co says it would generate $1.7 billion more in savings from cost-cutting to its manufacturing and research operations
** Including session's moves, PFE has fallen about 10% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。